IP Library › Granted Patent US 11,701,295
Granted Patent B2
US 11,701,295 · App. 17/344,343 · Granted Jul 18, 2023

Active compression decompression cardiopulmonary resuscitation chest compression feedback

Inventors: Gary A. Freeman (Waltham, MA); Guy R. Johnson (Gloucester, MA); James R. Homuth (Corcoran, MN); Keith Lurie (Minneapolis, MN); Anja Metzger (Lake Elmo, MN)
Assignee: ZOLL Medical Corporation
A61H31/005A61H31/02G16H20/30G16H20/40A61H2031/001A61H2031/002A61H2201/5061A61H2201/5064
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,701,295
App. No.
17/344,343
Granted
Jul 18, 2023
Kind
B2
Abstract

Systems and methods related to the field of cardiac resuscitation, and in particular to devices for assisting rescuers in performing cardio-pulmonary resuscitation (CPR) are described herein. The system includes an applicator device configured to provide ACD CPR treatment to a patient's chest according to a plurality of phases at least one sensor configured to be coupled to the patient's chest and to measure at least one parameter related to the ACD CPR treatment and information for determining whether at least one transition point of the ACD CPR treatment has been reached; and one or more processors configured to provide a feedback signal based on a parameter for administering ACD CPR treatment to the patient's chest according to a desired treatment protocol.

Claims (58)

1. A method for managing an active compression decompression (ACD) cardiopulmonary resuscitation (CPR) treatment to a patient in need of emergency assistance, the method comprising:

receiving, from at least one sensor coupled to the patient's chest, data comprising a displacement of at least a portion of the patient's chest and a force applied by an applicator device during the ACD CPR treatment, wherein the ACD CPR treatment comprises phases, the phases comprising at least an elevated compression phase, a non-elevated compression phase, an elevated decompression phase, and a non-elevated decompression phase;

processing the data comprising the displacement and the force during the ACD CPR treatment;

identifying a neutral point associated with a zero force being exerted on the patient's chest during a cycle of the ACD CPR treatment, the cycle comprising a continuous variation from a non-elevated compressed chest position during the non-elevated compression phase to an elevated decompressed chest position during the elevated decompression phase, wherein the neutral point changes over a course of the ACD CPR treatment;

determining, based on the neutral point, whether a transition point between a current phase and a next phase in the ACD CPR treatment has been reached; and

in response to determining that the transition point between the current phase and the next phase has been reached, automatically adjusting one or more application parameters for the applicator device to correspond to a subsequent phase of the ACD CPR treatment.

2. The method of claim 1 comprising:

providing an output for the applicator device to apply the force on the patient's chest according to the one or more application parameters.

3. The method of claim 1 , wherein the neutral point indicates a transition between an elevated position of the patient's chest above the neutral point and a non-elevated position of the patient's chest below the neutral point.

4. The method of claim 3 , wherein automatically adjusting one or more application parameters of the applicator device comprises:

providing a signal for operating an automated compressor of the applicator device.

5. The method of claim 4 , wherein determining whether the at least one transition point has been reached comprises evaluating at least one of distance information and force information.

6. The method of claim 1 , wherein the one or more application parameters comprise a release velocity during decompression upstroke for providing a negative intrathoracic pressure according to a treatment protocol.

7. The method of claim 1 , wherein the one or more application parameters comprise the force to be applied to the patient's chest during decompression upstroke according to a desired treatment protocol.

8. The method of claim 1 , wherein the one or more application parameters comprise a distance above the neutral point and a depth of compression below the neutral point.

9. The method of claim 1 , wherein the one or more application parameters comprise at least one of displacement, velocity, acceleration, time, work, power, pressure, direction and orientation.

10. The method of claim 1 , wherein the at least one transition point is at least one of between an elevated compression phase and a non-elevated compression phase, between the elevated decompression phase and the elevated compression phase, between the elevated decompression phase and a hold time above the neutral point, and between a hold time above the neutral point and the elevated compression phase.

11. The method of claim 10 , wherein the hold time is between about 50-200 milliseconds.

12. The method of claim 1 , wherein the at least one transition point is at least one of between the non-elevated compression phase and the non-elevated decompression phase, between the non-elevated compression phase and a hold time below the neutral point, and between hold time below the neutral point and the non-elevated decompression phase.

13. The method of claim 12 , wherein the hold time is between about 50-200 milliseconds.

14. The method of claim 1 , comprising:

selecting the hold time based on one or more physiological parameters.

15. The method of claim 1 , wherein the at least one transition point is between the non-elevated decompression phase and the elevated decompression phase.

16. The method of claim 1 , comprising:

displaying the one or more application parameters during the ACD CPR treatment.

17. The method of claim 16 , wherein displaying the one or more application parameters during the ACD CPR treatment comprises:

displaying at least one of information representing effectiveness of CPR and an indication of a phase of the ACD CPR treatment.

18. The method of claim 1 , wherein the zero force comprises zero static compression force and zero static decompression force being exerted on to the patient's chest during the ACD CPR treatment.

19. A system for managing an active compression decompression (ACD) cardiopulmonary resuscitation (CPR) treatment to a patient in need of emergency assistance, the system comprising:

an applicator device configured to provide the ACD CPR treatment to the patient's chest according to phases, the phases comprising at least an elevated compression phase, a non-elevated compression phase, an elevated decompression phase, and a non-elevated decompression phase;

at least one sensor configured to be coupled to the patient's chest and to measure a displacement of at least a portion of the patient's chest and a force applied by the applicator device during the ACD CPR treatment; and

one or more processors and a non-transitory computer readable storage medium encoded with a computer program comprising instructions that, when executed, cause the one or more processors to perform operations comprising:

processing the displacement and the force during the ACD CPR treatment,

identifying a neutral point associated with a zero force being exerted on the patient's chest during a cycle of the ACD CPR treatment, the cycle comprising a continuous variation from a non-elevated compressed chest position during the non-elevated compression phase to an elevated decompressed chest position during the elevated decompression phase, wherein the neutral point changes over a course of the ACD CPR treatment,

determining, based on the neutral point, whether at least one transition point between a current phase and a next phase in the ACD CPR treatment has been reached, and

in response to determining that the transition point between the current phase and the next phase in the ACD CPR treatment has been reached, adjusting one or more application parameters for the applicator device to correspond to a subsequent phase of the ACD CPR treatment.

20. The system of claim 19 , wherein the applicator device comprises a piston configured to apply the force on the at least the portion of the patient's chest according to the one or more application parameters.

21. The system of claim 19 , wherein the at least one sensor comprises a motion sensor and a force sensor.

22. The system of claim 21 , wherein the motion sensor measures information for determining whether the at least one transition point of the ACD CPR treatment has been reached.

23. The system of claim 21 , wherein the motion sensor comprises one or more accelerometers configured to detect an acceleration signal associated with the displacement of the at least the portion of the patient's chest.

24. The system of claim 23 , wherein the one or more accelerometers comprise a first accelerometer and a second accelerometer, the first accelerometer being configured to detect an acceleration signal associated with a first displacement of a first portion of the patient's chest and the second accelerometer being configured to detect an acceleration signal associated with a second displacement of a second portion of the patient's chest.

25. The system of claim 19 , wherein determining whether the at least one transition point has been reached comprises at least one of distance information and force information.

26. The system of claim 19 , wherein the one or more application parameters comprise a release velocity during decompression upstroke for providing a negative intrathoracic pressure according to a treatment protocol.

27. The system of claim 19 , wherein the one or more application parameters comprise the force to be applied to the patient's chest during decompression upstroke according to a desired treatment protocol.

28. The system of claim 19 , wherein the one or more application parameters comprise a distance above the neutral point and a depth of compression below the neutral point.

29. The system of claim 19 , wherein the one or more application parameters comprise at least one of displacement, velocity, acceleration, time, work, power, pressure, direction and orientation.

30. The system of claim 19 , wherein the at least one transition point is at least one of between an elevated compression phase and a non-elevated compression phase, between the elevated decompression phase and the elevated compression phase, between the elevated decompression phase and a hold time above the neutral point, and between a hold time above the neutral point and the elevated compression phase.

31. The system of claim 30 , wherein the hold time is between about 50-200 milliseconds.

32. The system of claim 19 , wherein the at least one transition point is at least one of between the non-elevated compression phase and the non-elevated decompression phase, between the non-elevated compression phase and a hold time below the neutral point, and between hold time below the neutral point and the non-elevated decompression phase.

33. The system of claim 32 , wherein the hold time is between about 50-200 milliseconds.

34. The system of claim 19 , wherein the at least one transition point is between the non-elevated decompression phase and the elevated decompression phase.

35. The system of claim 19 , comprising a user interface configured to display the one or more application parameters during the ACD CPR treatment.

36. The system of claim 35 , wherein the user interface is configured for displaying at least one of information representing effectiveness of CPR and an indication of a phase of the ACD CPR treatment.

37. The system of claim 36 , wherein the user interface is configured to be displayed on a device external to the system comprising at least one of a smartphone, a smartwatch, a tablet device, a monitor, a diagnostic device, and a defibrillator.

38. The system of claim 19 , wherein the applicator device comprises one or more accelerometers configured to detect an acceleration signal associated with displacement of the applicator device.

39. The system of claim 19 , comprising an adhesive pad configured to be adhered to at least a portion of a patient's chest.

40. The system of claim 19 , wherein the zero force comprises zero static compression force and zero static decompression force being exerted on to the patient's chest during the ACD CPR treatment.

41. The system of claim 19 , wherein the neutral point indicates a transition between an elevated position of the patient's chest above the neutral point and a non-elevated position of the patient's chest below the neutral point.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2021
From: FREEMAN, GARY A.; JOHNSON, GUY R.; HOMUTH, JAMES R.; LURIE, KEITH; METZGER, ANJA
To: ZOLL MEDICAL CORPORATION
Reel/Frame 056523/0460 →
Continuity (3)
Continuation 15720837 · Sep 29, 2017
Provisional Application 62402688 · Sep 30, 2016
Related Publication 20210369558A1 · Dec 2, 2021
Cited By (2)
US 12,213,937 US 12,329,714